Clinical Outcomes For Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From A Multiinstitutional Consortium Study | Latest News RSS feed

Clinical Outcomes For Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From A Multiinstitutional Consortium Study - Latest News


Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?

Gleason grading is an important predictor of prostate cancer (PCa) outcomes. Studies using surrogate PCa end points suggest outcomes for Gleason score ... by study investigators. Through systematic me... read more

Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer: Page 3 of 3

The lowest CSM was observed in patients with Gleason score 7, clinical ... prostate cancer: results of a single-institution series with long-term follow-up. Eur Urol. 2017;72:289-92. 80. Sooriakumaran ... read more

Why Genomic Health Is A Solid Long-Term Buy

The test results are reported as a Genomic Prostate Score ... patients; specifically, treatment intensity decreased for 28% of patients and increased for 10% of patients. The U.S. study conducted in c... read more

Looking for another news?


Genomic Health Up on Fresh Cancer Study Data

This, in turn, helps both physicians and patients to take more improved treatment decisions. In the prostate ... of the clinical validation study. For both biopsy and radical prostatectomy specimen ev... read more


Intermediate risk prostate cancer may be well controlled with brachytherapy alone

NRG Oncology/RTOG 0232 is a phase III, multi-institutional ... (i.e., clinical stage T1c-T2b) and enrolled in the trial between 2003 and 2012. Prostate cancer risk groups are assigned based on the pro... read more

ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer

The combination of PSA, Gleason score, and clinical ... a larger, multi-institutional protocol, comparing it with standard techniques to determine whether its initial increased cost is justified. Zele... read more

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

His clinical research falls into three broad areas: randomized trials, surgical outcomes ... on patient preferences. He has a strong interest in teaching statistics and he writes the statistics column ... read more

Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer

Clinical stage, PSA, and Gleason score, as well as PSADT all predicted intervention among those starting with AS. However, the outcomes were not explicitly ... option for carefully selected men with i... read more

Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer

Results in patients with favourable tumours (T1 or T2 tumour, Gleason score of 6 or lower, serum PSA level of 10 ng/mL [μg/L ... PSA level influence the outcome of any definitive treatment of localize... read more

The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria

Cases had a median serum diagnostic PSA of 73 ng/ml, and 38% had a Gleason score 8–10 tumor ... study demonstrated the ability to ascertain and recruit participants at UCH and collect epidemiological, ... read more

Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer: Page 2 of 3

Despite insufficient data to draw conclusions regarding the effectiveness of aggressive therapies on overall or cancer-specific survival of patients with oligometastatic prostate cancer ... time (< 6 ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us